Medical-imaging contrast media market booms

Increased incidence of vascular diseases and improved medical-imaging technologies expand the application base for contrast media. According to a new study from US market-research group Frost & Sullivan, sales of medical-imaging contrast media will see an impressive 58 per cent rise until 2013.

Photo: Medical-imaging contrast media market booms

Modern medical-imaging technologies, like MR angiography and CT angiography, improve the diagnosis of cardiovascular disease, which occurs more frequently in an ageing population.

The market is on the move. “Vendors focus on innovative medical-imaging technologies, which require the use of contrast media to reinvigorate their bottom lines,” says A. J. Ajibade, Frost & Sullivan research analyst. “Group purchasing organizations (GPO’s) use their collective buying power to define the market and obtain hefty discounts.”
Sales improve only for some market participants, while vendors not involved in sometimes exclusive GPO healthcare contracts could face financial difficulties.

“But it is imperative, that contrast-media products are compatible with new applications and potential products are not going to be locked out of availability to healthcare providers”, argues Frost & Sullivan. Lobbying efforts should focus on methods, that provide healthcare organizations equal accessibility.

06.08.2007

More on the subject:

Related articles

Photo

Article • Exploring imaging advances and their impact on radiographers

‘The future of breast MRI is bright’

Breast MRI has emerged as a powerful diagnostic tool, particularly for women with dense breast tissue where traditional mammography faces limitations. In her presentation at ECR 2025, radiographer…

Photo

News • Brain MRI analysis

AI tool tracks effectiveness of multiple sclerosis treatments

A new AI tool can extract key information from brain MRI scans of multiple sclerosis (MS) patients. This could be used to improve disease and treatment response monitoring.

Photo

Sponsored • Corporate presentation at radiology congress

Bayer at ECR 2025: Less dose, more AI and sustainability

Contrast agents, AI and circular economy: Bayer presented new developments for radiology at the ECR Congress. Particular emphasis was placed on digital assistance systems and sustainability.

Related products

Subscribe to Newsletter